<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(10)</volume><submitter>Wang BY</submitter><pubmed_abstract>The alkaline intracellular environment of cancer cells is critical for cell proliferation and controlled by various plasma membrane transporters including Na+/H+ exchangers (NHEs). NHEs can also mediate cell behavior by regulating signaling transduction. In this study, we investigated the role of NHE7 in cancer stem cell (CSC) activity in non-small cell lung cancer (NSCLC) cells and the potential therapeutic implications of targeting NHE7 and the associated immune checkpoint molecule PD-L1. By analyzing the database from The Cancer Genome Atlas, we found a positive correlation between SLC9A7 mRNA levels (the gene encoding NHE7) and poor overall survival in lung adenocarcinoma patients. Using 5-(N-ethyl-N-isopropyl)-Amiloride (EIPA) to inhibit NHE7 activity, we observed disrupted cell cycle</pubmed_abstract><journal>American journal of cancer research</journal><pagination>4721-4733</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10636675</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Inhibition of Na+/H+ exchanger (NHE) 7 by 5-(N-ethyl-N-isopropyl)-Amiloride displays anti-cancer activity in non-small cell lung cancer by disrupting cancer stem cell activity and downregulating PD-L1 expression.</pubmed_title><pmcid>PMC10636675</pmcid><pubmed_authors>Shen HT</pubmed_authors><pubmed_authors>Chang WW</pubmed_authors><pubmed_authors>Wang BY</pubmed_authors><pubmed_authors>Chien PJ</pubmed_authors><pubmed_authors>Lee YL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inhibition of Na+/H+ exchanger (NHE) 7 by 5-(N-ethyl-N-isopropyl)-Amiloride displays anti-cancer activity in non-small cell lung cancer by disrupting cancer stem cell activity and downregulating PD-L1 expression.</name><description>The alkaline intracellular environment of cancer cells is critical for cell proliferation and controlled by various plasma membrane transporters including Na+/H+ exchangers (NHEs). NHEs can also mediate cell behavior by regulating signaling transduction. In this study, we investigated the role of NHE7 in cancer stem cell (CSC) activity in non-small cell lung cancer (NSCLC) cells and the potential therapeutic implications of targeting NHE7 and the associated immune checkpoint molecule PD-L1. By analyzing the database from The Cancer Genome Atlas, we found a positive correlation between SLC9A7 mRNA levels (the gene encoding NHE7) and poor overall survival in lung adenocarcinoma patients. Using 5-(N-ethyl-N-isopropyl)-Amiloride (EIPA) to inhibit NHE7 activity, we observed disrupted cell cycle</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2025-04-26T17:14:15.794Z</modification><creation>2024-11-07T13:52:29.401Z</creation></dates><accession>S-EPMC10636675</accession><cross_references><pubmed>37970357</pubmed></cross_references></HashMap>